The JETREA brand, founded in 2010 (Belgium), from 11 sister brands and 2214 competing brands. The JETREA brand is owned by ThromboGenics, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0003846632. JETREA belongs to the Biotechnology business sector.

JETREA is a brand of ThromboGenics (OXUR) Share price

International deposit : 2010 Business sector Biotechnology

Share price and profitability of the share ThromboGenics (JETREA)

Buy ThromboGenics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.00

Portfolio valuation
ThromboGenics (JETREA) over 5 years* EUR 0.00

Stock market history ThromboGenics (JETREA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ThromboGenics

THROMBOGENICS
THROMBOGENICS
See more brands of ThromboGenics

Rival brands
JETREA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS